Publication Author: Basu_Anirban
-
Quantitative Methods for Valuing Comparative Effectiveness Information.
Basu A, Meltzer D. Quantitative Methods for Valuing Comparative Effectiveness Information. Biopharm Rep. 2010 Fall;17(2):2-10.
rakerr2
-
Estimating lifetime or episode-of-illness costs under censoring.
Basu A, Manning WG. Estimating lifetime or episode-of-illness costs under censoring. Health Econ. 2010 Sep;19(9):1010-28. Erratum in: Health Econ. 2011 Jan;20(1):125-6.
rakerr2
-
Relationship between quality of care of hospitalized vulnerable elders and postdischarge mortality.
Arora VM, Fish M, Basu A, Olson J, Plein C, Suresh K, Sachs G, Meltzer DO. Relationship between quality of care of hospitalized vulnerable elders and postdischarge mortality. J Am Geriatr Soc. 2010 Sep;58(9):1642-8. doi: 10.1111/j.1532-5415.2010.03024.x.
rakerr2
-
The cost-effectiveness of continuous glucose monitoring in type 1 diabetes.
Huang ES, O’Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The cost-effectiveness of continuous glucose monitor
rakerr2
-
Forecasting distribution of body mass index in the United States: is there more room for growth?
Basu A. Forecasting distribution of body mass index in the United States: is there more room for growth? Med Decis Making. 2010 May-Jun;30(3):E1-E11. Epub 2009 Nov 25.
rakerr2
-
A time tradeoff method for eliciting partner’s quality of life due to patient’s health states in prostate cancer.
Basu A, Dale W, Elstein A, Meltzer D. A time tradeoff method for eliciting partner’s quality of life due to patient’s health states in prostate cancer. Med Decis Making. 2010 May-Jun;30(3):355-65. Epub 2010 Mar 12.
rakerr2
-
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries’ prescription utilization and expenditures.
Basu A, Yin W, Alexander GC. Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries’ prescription utilization and expenditures. Health Serv Res. 2010 Feb;45(1):133-51. Epub 2009 Dec 4.
rakerr2
-
Effect of clinician advice and patient preparedness to quit on subsequent quit attempts in hospitalized smokers.
Shah LM, King AC, Basu A, Krishnan JA, Borden WB, Meltzer D, Arora V. Effect of clinician advice and patient preparedness to quit on subsequent quit attempts in hospitalized smokers. J Hosp Med. 2010 Jan;5(1):26-32.
rakerr2
-
Projecting the future diabetes population size and related costs for the U.S.
Huang ES, Basu A, O’Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009 Dec;32(12):2225-9.
rakerr2
-
Individualization at the heart of comparative effectiveness research: the time for i-CER has come.
Basu A. Individualization at the heart of comparative effectiveness research: the time for i-CER has come. Med Decis Making. 2009 Nov-Dec;29(6):NP9-NP11.
rakerr2